Journal
HEART
Volume 99, Issue 18, Pages 1330-1335Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/heartjnl-2013-303648
Keywords
MYOCARDIAL ISCHAEMIA AND INFARCTION (IHD)
Categories
Funding
- University of Edinburgh
- British Heart Foundation [PG/2001068, SS/CH/92010, PG/07/ 012, CH/09/002]
- British Heart Foundation [FS/10/024/28266] Funding Source: researchfish
Ask authors/readers for more resources
Objective The inflammatory cytokine, tumour necrosis factor (TNF-), exerts deleterious cardiovascular effects. We wished to determine the effects of TNF- antagonism on endothelial function and platelet activation in patients with acute myocardial infarction. Design and setting and patients A double-blind, parallel group, randomised controlled trial performed in a tertiary referral cardiac centre. 26 patients presenting with acute myocardial infarction randomised to receive an intravenous infusion of etanercept (10mg) or saline placebo. Main outcome measures Leucocyte count, plasma cytokine concentrations, flow cytometric measures of platelet activation and peripheral vasomotor and fibrinolytic function were determined before and 24h after study intervention. Results Consistent with effective conjugation of circulating TNF-, plasma TNF- concentrations increased in all patients following etanercept (25415 vs 0.12 +/- 0.02 pg/ml; p<0.0001), but not saline infusion. Etanercept treatment reduced neutrophil (7.4 +/- 0.6 vs 8.8 +/- 0.6x10(9) cells/l; p=0.03) and plasma interleukin-6 concentrations (5.8 +/- 2.0 vs 10.6 +/- 4.0pg/ml; p=0.012) at 24h but increased platelet-monocyte aggregation (30 +/- 5 vs 20 +/- 3%; p=0.02). Vasodilatation in response to substance P, acetylcholine and sodium nitroprusside, and acute tissue plasminogen activator release were unaffected by either treatment (p>0.1 for all). Conclusions Following acute myocardial infarction, etanercept reduces systemic inflammation but increases platelet activation without affecting peripheral vasomotor or fibrinolytic function. We conclude that TNF- antagonism is unlikely to be a beneficial therapeutic strategy in patients with acute myocardial infarction.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available